GCP
KROS icon

GSA Capital Partners’s Keros Therapeutics KROS Stock Holding History

GSA Capital Partners’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,346
Closed -$1.04M – 1966
2025
Q4 		$1.04M Buy
51,346
+26,046
+103% +$457K 0.09% 337
2025
Q3 		$400K Sell
25,300
-36,155
-59% -$534K 0.03% 1004
2025
Q2 		$820K Buy
+61,455
New +$830K 0.06% 582
2025
Q1 		– Sell
-11,158
Closed -$177K – 1879
2024
Q4 		$177K Buy
+11,158
New +$580K 0.01% 1441
2024
Q2 		– Sell
-8,538
Closed -$565K – 1855
2024
Q1 		$565K Buy
8,538
+1,736
+26% +$103K 0.04% 801
2023
Q4 		$270K Sell
6,802
-10,359
-60% -$325K 0.02% 1170
2023
Q3 		$547K Buy
+17,161
New +$641K 0.05% 736
2023
Q2 		– Sell
-18,324
Closed -$782K – 1743
2023
Q1 		$782K Buy
18,324
+10,151
+124% +$513K 0.08% 454
2022
Q4 		$392K Buy
+8,173
New +$382K 0.05% 755

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return